The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  25 (2024)
Volume  24 (2023)
Volume  23 (2022)
Volume  22 (2021)
Volume  21 (2020)
Volume  20 (2019)
Volume  19 (2018)
Volume  18 (2017)
Volume  17 (2016)
Volume  16 (2015)
Volume  15 (2014)
Volume  14 (2013)
Volume  13 (2012)
Volume  12 (2011)
Volume  11 (2010)
Volume  10 (2009)
Volume  9 (2008)
Volume  8 (2007)
Volume  7 (2006)
Volume  6 (2005)
Volume  5 (2004)
Volume  4 (2003)
Volume  3 (2002)
Volume  2 (2001)
Volume  1 (1999)
Related articles

VOLUME 15 , ISSUE 6 ( November-December, 2014 ) > List of Articles

REVIEW ARTICLE

Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature

Syed Rashid Habib, Ana Pejcic, Rosnah Binti Zain

Citation Information : Habib SR, Pejcic A, Zain RB. Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature. J Contemp Dent Pract 2014; 15 (6):812-817.

DOI: 10.5005/jp-journals-10024-1623

Published Online: 01-05-2015

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Awan KH, Patil S, Habib SR, Pejcic A, Zain RB. Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature. J Contemp Dent Pract 2014;15(6):812-817.

PDF Share
  1. Atrophia idiopathica (tropica) mucosae oris. London: Proceedings of the 11th International Dental Congress. 1952.
  2. Fibrosis of the palate and pillars. Ind J Otolaryngol 1953;4:1.
  3. J Oral Pathol Med 2007 Nov;36(10):575-580.
  4. Oral submucous fibrosis: an unusual disease. JNJ Dent Assoc Spring 1997;68(2):17-19.
  5. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncology 2006 Jul;42(6):561-568.
  6. Oral submucous fibrosis: a review. Annals of the Academy of Medicine, Singapore. 1989 Sep;18(5):603-607.
  7. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979 May;47(5):453-457.
  8. Oral submucous fibrosis: its pathogenesis and management. British Dent J 1986 Jun 21;160(12):429-434.
  9. Serum levels of iron and proteins in oral submucous fibrosis (OSMF). Annals of dentistry. Winter 1990;49(2):23-25.
  10. Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immunodiffusion. Int J Oral Surg 1985 Dec;14(6):533-537.
  11. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 1987 Apr 15;43(4):391-393.
  12. The oral health consequences of chewing areca nut. Addiction Biology 2002 Jan;7(1):115-125.
  13. Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1995 Oct;24(9):407-412.
  14. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 1999 Feb;28(2):59-63.
  15. Oral submucous fibrosis patients have altered levels of cytokine production. Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2000 Mar;29(3):123-128.
  16. Management of oral submucous fibrosis: a conservative approach. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 1991 Aug;49(8):788-791.
  17. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. Journal of oral pathology and medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1995 Oct;24(9):402-406.
  18. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutrition and Cancer. 1997;27(1):41-47.
  19. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987 Dec;16(6):695-699.
  20. Clinical treatment observation of tea pigment for oral submucous fibrosis. Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China J Stomatology 1998 Feb;16(1):50-52.
  21. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 2007 Feb;103(2):207-213.
  22. Oral submucous fibrosis—a new treatment regimen. J Oral and Maxillofac Surgery 1988 Oct;46(10):830-833.
  23. Oral submucous fibrosis-treatment with hyalase. J Laryngol Otology 1985 Jan;99(1):57-59.
  24. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Ind J Dental Res 2006 Oct-Dec;17(4):190-198.
  25. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Association Physicians India 2003 Nov; 51:1055-1060.
  26. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Letters 1997 Jun 24;116(2):265-269.
  27. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001 Nov;30(10):618-625.
  28. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathology Med 2001 Jan;30(1):12-21.
  29. Interventions for the management of oral submucous fibrosis. The Cochrane database of systematic reviews. 2008; (4):CD007156.
  30. Subepithelial changes in oral submucous fibrosis. Acta pathologica et microbiologica Scandinavica 1967;70(2):161-173.
  31. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med 1994 Oct;23(9):394-398.
  32. Collagenase activity in oral submucous fibrosis. Proceedings of the National Science Council, Republic of China. Part B, Life Sci 1992 Apr;16(2):106-110.
  33. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2003 Oct;39(7):728-735.
  34. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003 Jun;39(4):367-372.
  35. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Diseases 2007 Jul;13(4):407-413.
  36. Pentoxifylline. J Am Academy of Dermatol 1994 Apr;30(4):603-621.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.